In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases - PubMed (original) (raw)

In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases

I Krause et al. Transfus Med. 2002 Apr.

Abstract

The identification of specific antimicrobial activity of intravenous immunoglobulin (IVIG) preparations against particular microbial pathogens can assist in determining their therapeutic potential for specific infectious diseases. We analysed five different commercial IVIG preparations for the presence of antibodies directed against a large panel of viral, bacterial, fungal and parasitic pathogens. All IVIG batches contained high activity against herpesviruses types 1, 2, 6 and 7, as well as against varicella zoster virus, Epstein-Barr virus (EBV), measles, mumps, rubella and parvovirus B19. Some IVIG batches also had a significant activity against adenovirus and Saint Louis encephalitis virus. The IVIGs held high activity against several bacterial pathogens, including Mycoplasma pneumonia, Chlamydia pneumonia, Helicobacter pylori and tetanus. No activity was found against various parasitic and fungal pathogens. Our findings may provide further support for the use of IVIG for the prevention and treatment of infections caused by specific viral and bacterial pathogens.

PubMed Disclaimer

Cited by

Intravenous immunoglobulin for treatment of pemphigus.
Akerman L, Mimouni D, David M. Akerman L, et al. Clin Rev Allergy Immunol. 2005 Dec;29(3):289-94. doi: 10.1385/CRIAI:29:3:289. Clin Rev Allergy Immunol. 2005. PMID: 16391404 Review.
SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.
Prete M, Favoino E, Catacchio G, Racanelli V, Perosa F. Prete M, et al. Int J Mol Sci. 2020 May 10;21(9):3377. doi: 10.3390/ijms21093377. Int J Mol Sci. 2020. PMID: 32397684 Free PMC article. Review.
A single center experience of intravenous immunoglobulin treatment in Covid-19.
Omma A, Erden A, Armağan B, Güven SC, Karakaş Ö, Şahiner ES, Erdem D, İzdeş S, Ateş İ, Küçükşahin O. Omma A, et al. Int Immunopharmacol. 2021 Sep;98:107891. doi: 10.1016/j.intimp.2021.107891. Epub 2021 Jun 14. Int Immunopharmacol. 2021. PMID: 34153671 Free PMC article.
The protective role of immunoglobulins in fungal infections and inflammation.
Elluru SR, Kaveri SV, Bayry J. Elluru SR, et al. Semin Immunopathol. 2015 Mar;37(2):187-97. doi: 10.1007/s00281-014-0466-0. Epub 2014 Nov 18. Semin Immunopathol. 2015. PMID: 25404121 Review.
Intravenous immunoglobulin for the treatment of childhood encephalitis.
Iro MA, Martin NG, Absoud M, Pollard AJ. Iro MA, et al. Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD011367. doi: 10.1002/14651858.CD011367.pub2. Cochrane Database Syst Rev. 2017. PMID: 28967695 Free PMC article. Review.

In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases - PubMed (original) (raw)